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Introduction
Binding of EGF to its receptor (EGF receptor [EGFR]) at the 
cell surface initiates a signal transduction process that involves 
a dynamic network of molecular interactions and modifications 
ultimately leading to cell survival, proliferation, and differentia-
tion (Schlessinger, 2000). EGF binding also results in rapid   
internalization of activated receptors and targeting of internal-
ized EGF–receptor complexes to lysosomes for degradation (for 
review see Sorkin and Goh, 2009). Acceleration of internaliza-
tion and lysosomal targeting leads to receptor down-regulation, 
which serves to decrease the number of activated receptors in 
the cell and prevent excessive signaling. For instance, acti-
vation of phosphoinositide-3-kinase and protein kinase B/AKT 
is thought to occur mostly from the plasma membrane and is, 
therefore, negatively regulated by endocytosis (for review see 
Sorkin and von Zastrow, 2009). However, activated EGFR can 
continue to emit signals from endosomes. Specifically, endocytosis   
has been proposed to be necessary for the normal duration and 
intensity  of  the  EGFR  signaling  to  mitogen-activated  protein 
kinases (MAPKs; Vieira et al., 1996; Teis et al., 2006; for re-
views see Fehrenbacher et al., 2009; Sorkin and von Zastrow, 
2009). Therefore, endocytosis can have multiple and possibly 
opposing effects on signal transduction processes. The analysis 
of the role of EGFR endocytosis in signaling has been difficult 
because  the  molecular  mechanisms  of  EGFR  internalization   
remain poorly understood, and experimental approaches to spe-
cifically inhibit EGFR internalization have not been developed. 
In particular, mutants of EGFR that are not internalized but main-
tain a full signaling capacity have not been generated.
Endocytosis of EGFR has historically been and remains to 
be the most popular experimental system for the study of ligand-
induced endocytosis. Endocytosis via clathrin-coated pits is the 
main pathway of activated EGFR internalization observed under 
most physiological conditions, although several examples of 
E
ndocytosis of the epidermal growth factor recep-
tor (EGFR) is important for the regulation of EGFR 
signaling. However, EGFR endocytosis mechanisms 
are  poorly  understood,  which  precludes  development  of 
approaches to specifically inhibit EGFR endocytosis and 
analyze its impact on signaling. Using a combination of 
receptor mutagenesis and RNA interference, we demon-
strate  that  clathrin-dependent  internalization  of  activated 
EGFR is regulated by four mechanisms, which function in 
a redundant and cooperative fashion. These mechanisms 
involve ubiquitination of the receptor kinase domain, the 
clathrin adaptor complex AP-2, the Grb2 adaptor protein, 
and three C-terminal lysine residues (K1155, K1158, and 
K1164), which are acetylated, a novel posttranslational 
modification for the EGFR. Based on these findings, the first 
internalization-defective EGFR mutant with functional ki-
nase and normal tyrosine phosphorylation was generated. 
Analysis of the signaling kinetics of this mutant revealed that 
EGFR internalization is required for the sustained activation 
of protein kinase B/AKT but not for the activation of mitogen- 
activated protein kinase.
Multiple mechanisms collectively regulate  
clathrin-mediated endocytosis of the epidermal 
growth factor receptor
Lai Kuan Goh,
1 Fangtian Huang,
1 Woong Kim,
3 Steven Gygi,
3 and Alexander Sorkin
1,2
1Department of Pharmacology, School of Medicine, University of Colorado Denver, Aurora, CO 80045
2Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
3Department of Cell Biology, Harvard Medical School, Boston, MA 02115
©  2010  Goh  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 189 • NUMBER 5 • 2010   872
accumulated in endosomes. This mutant was used to demonstrate 
the impact of slow EGFR endocytosis on signaling dynamics, 
particularly, on the sustained activity along the EGFR–AKT sig-
naling axis.
Results
Lys residues in the EGFR kinase and  
C-terminal domains play redundant roles  
in receptor internalization
We have previously described an EGFR mutant with 15 Lys to 
arginine (15KR) mutations in the kinase domain (Huang et al., 
2007). Despite negligible residual ubiquitination, 15KR was still 
internalized as efficiently as the wild-type (wt) EGFR, suggesting 
that receptor ubiquitination is not essential for internalization. 
Because there are six Lys in the C-terminal tail of EGFR (resi-
dues 1037, 1075, 1136, 1155, 1158, and 1164), we examined 
whether these Lys represent cryptic ubiquitination sites, which 
are undetectable by mass spectrometry (MS) and Western blotting, 
could be important for EGFR internalization. To this end, all six 
Lys were mutated to arginines in the wtEGFR and 15KR mutant, 
resulting in the 6KR-C and 21KR mutants, respectively (Fig. 1 A). 
We found that measurements of EGF endocytosis rates in cells 
transiently expressing EGFR yield low rates when compared 
with the typical rate of CME and the endocytic rates of endoge-
nous as well as stably expressed heterologous EGFR (Fig. S1; 
Carter and Sorkin, 1998). To accurately measure the endocytic 
rates, EGFR mutants were stably expressed in porcine aortic en-
dothelial (PAE) cells that do not express endogenous EGFR and 
detectable amounts of other ErbBs. For each EGFR mutant, sev-
eral single-cell stable clones were tested to account for potential 
clonal variability. Finally, internalization assays were performed 
using low, physiological concentrations of radiolabeled 
125I-EGF 
(1 ng/ml; plasma concentration of EGF), conditions favoring EGFR 
internalization through the CME pathway.
As shown in Fig. 1 B, 6KR-C mutant was internalized 
at a high rate. In contrast, several clones of 21KR-expressing 
cells internalized 
125I-EGF much slower than 15KR and wtEGFR- 
expressing cells (Fig. 1 C). EGF-induced tyrosine phosphoryla-
tion of 21KR mutants was similar to that of wtEGFR, which in-
dicates that the decrease in the internalization rate was not caused 
by altered tyrosine phosphorylation of the receptor (Fig. 1 D). 
Overall, these data suggest that Lys within the C-terminal tail 
play a role in EGFR internalization only when ubiquitination of 
the kinase domain is eliminated. Therefore, we hypothesized that 
Lys within the kinase domain and the C-terminal tail of EGFR are 
involved in two redundant mechanisms of EGFR internalization.
AP-2–binding motifs in the EGFR are 
involved in receptor internalization
Because the 21KR mutant exhibits a 50% reduction in the rate of 
internalization (Fig. 1 C), additional mechanisms responsible for 
the residual internalization of the 21KR mutant must exist. The 
interaction of EGFR with the major cargo-binding protein complex 
in coated pits, AP-2, has been previously demonstrated, although 
functional experiments have shown that this interaction is not   
essential for EGFR internalization (Sorkin et al., 1996; Nesterov   
clathrin-independent EGFR endocytosis have been reported 
(Yamazaki et al., 2002; Sigismund et al., 2005; Orth et al., 2006). 
Several conventional mechanisms of cargo recruitment into clathrin- 
coated pits have been tested for their role in EGFR internaliza-
tion. An early study demonstrated interaction of EGFR with the 
clathrin adaptor protein complex AP-2 (Sorkin and Carpenter, 
1993). Classical tyrosine-based motif (Y
974RAL) in EGFR is es-
sential for this interaction, although an involvement of another 
AP-2–binding, dileucine motif (Leu
1010/Leu
1011 [LL
1010/1011]) in 
EGFR has also been proposed (Sorkin et al., 1996; Huang et al., 
2003). However, functional assays demonstrated that neither the 
YRAL motif that interacts with the 2 subunit of AP-2 nor the 
LL motif is necessary for clathrin-mediated endocytosis (CME) 
of EGFR (Sorkin et al., 1996; Nesterov et al., 1999; Huang et al., 
2003). Testing the effect of AP-2 depletion by siRNAs on EGFR 
internalization has yielded conflicting results, showing either an 
important role of AP-2 (Huang et al., 2004; Johannessen et al., 
2006; Rappoport and Simon, 2009) or lack thereof (Motley 
et al., 2003).
Another proposed mechanism of internalization involves 
cargo ubiquitination and interaction of the ubiquitinated cargo 
with ubiquitin adaptors in coated pits, such as epsin 1 and Eps15. 
EGFR is ubiquitinated by the E3 ubiquitin ligase Cbl, which 
binds to activated EGFR directly and indirectly through the Grb2 
adaptor protein (Levkowitz et al., 1999; Waterman et al., 2002). 
However, the ubiquitin-based mechanism has also been ruled out 
as essential for EGFR internalization. First, mutation of 15 Lys 
residues in the kinase domain of EGFR, including six major ubiq-
uitin conjugation sites, essentially abolished receptor ubiquitina-
tion but did not affect the rate of EGFR internalization (Huang   
et al., 2007). Second, siRNA depletion of epsin 1 alone or 
together with depletion of Eps15 and Eps15R did not specifi-
cally affect the CME of EGFR (Huang et al., 2004; Sigismund   
et al., 2005; Vanden Broeck and De Wolf, 2006; Chen and Zhuang, 
2008). Mouse embryonic fibroblasts derived from the double– 
epsin 1/2 knockout exhibited normal EGFR endocytosis (Chen   
et al., 2009). In contrast, a strong effect of epsin 1 knockdown on 
EGFR internalization in HeLa cells has been reported in a previ-
ous study (Kazazic et al., 2009). The latter study suggested that 
there might be cryptic ubiquitination of the EGFR Lys mutants, 
which could potentially mediate receptor internalization through 
interaction with epsin 1.
Controversies in the reported effects of EGFR mutagenesis 
and siRNA depletion of AP-2 and epsin on EGFR endocytosis 
prompted us to test whether (a) ubiquitin- and AP-2–based inter-
nalization mechanisms have a redundant function in EGFR endo-
cytosis and whether (b) Lys residues in the EGFR outside of its   
kinase domain are involved in the ubiquitin-dependent endo-
cytosis. Thus, we show that there are at least four either completely 
redundant or partially interrelated mechanisms that participate in 
EGFR internalization through clathrin-coated pits. These mecha-
nisms involve ubiquitination of the receptor kinase domain, re-
ceptor interaction with AP-2, C-terminal Lys residues, and Grb2. 
Consecutive elimination of the molecular determinants in EGFR, 
which  participate  in  multiple  internalization  mechanisms, 
led to the generation of a novel EGFR mutant that preserves nor-
mal signaling capacity, yet is very slowly internalized and not 873 EGF receptor endocytosis • Goh et al.
of the EGFR kinase, c-Cbl and Shc, to the extent similar to that 
observed  in  cells  expressing  wtEGFR  (Fig.  S3).  Collectively, 
these data suggest that the defective internalization of 21KRAP2 
and other mutants is not caused by the impaired kinase activity.
The clathrin-dependent endocytosis of EGFR has limited 
capacity and is saturated when high concentrations of EGF- 
occupied receptors are present at the cell surface. In turn, the satu-
ration leads to the decrease in the specific internalization rate of 
EGF, as the contribution of a slow clathrin-independent endo-
cytosis in the overall uptake of EGF is increased (Lund et al., 
1990). Because various clones of PAE cells express different lev-
els of EGFR mutants (Fig. S2), saturation of the CME pathway   
et al., 1999; Jiang et al., 2003). To investigate whether AP-2 is one 
of the several mechanisms involved in EGFR endocytosis, two 
AP-2–binding motifs in EGFR, Y
974RAL and LL
1010/1011, were 
mutated in the 15KR and 21KR constructs (15KRAP2 and 
21KRAP2 mutants; Fig. 2 A). Interestingly, although mutations 
of these AP-2–binding motifs in wtEGFR (wtAP2) did not af-
fect the internalization rate, the same mutations in conjunction 
with 15KR or 21KR mutations significantly reduced internaliza-
tion rates of 1 ng/ml 
125I-EGF (Fig. 2 B). Importantly, all mutants 
used in this study preserved normal EGF-induced tyrosine   
phosphorylation (Fig. S2). Moreover, upon EGF stimulation, 
21KRAP2 was capable of phosphorylating two direct substrates 
Figure  1.  Mutation  of  Lys  residues  in  the   
C terminus decreases internalization of 
125I-EGF   
by the 15KR mutant. (A) Schematic represen-
tation  of  6KR-C  and  21KR  EGFR  mutants  in 
which six Lys were replaced by arginines in 
the C-terminal tail of wtEGFR and 15KR, re-
spectively. (B) Time course of 1 ng/ml 
125I-EGF 
internalization in PAE cells expressing wtEGFR 
(blue)  or  6KR-C  (orange)  receptor.  (C)  Time 
course of 1 ng/ml 
125I-EGF internalization in 
various single-cell clones of PAE cells express-
ing  wtEGFR  (blue),  15KR  (green),  or  21KR 
(red). (D) PAE cells expressing wtEGFR, 15KR, 
and  21KR  were  untreated  or  treated  with   
20 ng/ml EGF for 5 min at 37°C, and EGFR 
was immunoprecipitated (IP). Immunoprecipi-
tates  were  probed  by  Western  blotting  with 
antibodies to ubiquitin (Ub), phosphotyrosine 
(pY20),  and  EGFR  (1005).  MW,  molecular 
weight; WB, Western blot.
Figure  2.  Mutation  of  AP-2–binding  motifs 
(Y
974RAL and LL
1010/1011) decreases internaliza-
tion of 
125I-EGF by the 15KR and 21KR mutants. 
(A)  Schematic  representation  of  WTAP2, 
15KRAP2, and 21KRAP2 EGFR mutants in 
which Tyr974 and LL
1010/1011 were mutated to 
alanines in wtEGFR, 15KR, and 21KR mutants, 
respectively. (B) Summary of 1 ng/ml 
125I-EGF 
internalization experiments performed in sev-
eral single-cell clones of PAE cells expressing 
wtEGFR, WTAP2, 15KR, 15KRAP2, 21KR, 
or 21KRAP2 receptors. Bars represent SEM 
from  three  to  four  independent  experiments.   
(C) Internalization saturation plots are shown. 
Specific internalization rate constant (ke) was 
measured  in  several  clones  of  PAE  cells  ex-
pressing  wtEGFR  or  various  EGFR  mutants 
treated  with  1–20  ng/ml 
125I-EGF.  ke  values 
are plotted against the number of surface EGFR   
occupied  by 
125I-EGF  per  cell  measured  as 
the amount of surface 
125I-EGF after 5 min of   
continuous 
125I-EGF internalization at 37°C.JCB • VOLUME 189 • NUMBER 5 • 2010   874
into clathrin-coated pit, an equilibrium-coated pit localization 
assay was performed as previously described (Sorkina et al., 
2002; Jiang et al., 2003). Cells stably expressing similar levels 
of wtEGFR, wtAP2, 21KR, or 21KRAP2 were transiently 
transfected with 2-YFP to mark plasma membrane clathrin-
coated pits and vesicles. The cells were incubated with 4 ng/ml   
EGF-rhodamine (EGF-Rh) at 4°C for 45 min to achieve an equilib-
rium so that EGF-Rh binding to surface receptors and interaction 
of EGF-Rh–EGFR complexes with coated pit proteins could 
take place in the absence of endocytosis. Three-dimensional 
deconvolution image analysis revealed that EGF-Rh dots were 
often colocalized with 2-YFP dots (coated pits) in cells ex-
pressing either wtEGFR or wtAP2 mutant, and the extent of 
EGF-Rh colocalization with coated pits was 10–11% (Fig. 4, 
A and C). Surprisingly, 21KR mutant was also efficiently con-
centrated in coated pits despite its slow endocytosis (Fig. 4 A).   
In contrast, 21KRAP2 mutant was diffusely distributed in the 
plasma membrane and accumulated in membrane ruffles with few 
examples of colocalization between EGF-Rh dots and 2-YFP 
(Fig. 4 A). The extent of colocalization of rhodamine and YFP 
dots in these cells was as low as 3% (Fig. 4 C).
The discrepancy between slow endocytosis and normal re-
cruitment of 21KR to clathrin-coated pits at 4°C could be a result 
of the long incubation of cells with EGF-Rh (45 min) at 4°C,   
allowing the process of receptor interaction with coated pits to 
reach the equilibrium. Under such conditions, moderate differ-
ences in the binding affinity of wtEGFR and 21KR to coated pits 
may not be revealed. For instance, internalization assay that in-
cluded long preincubation of cells with EGF at 4°C did not reveal 
the effect of AP-2 siRNA depletion on EGF internalization, 
whereas the assay using a short time course at 37°C did demon-
strate a role of AP-2 (Motley et al., 2003; Huang et al., 2004;   
Johannessen et al., 2006; Rappoport and Simon, 2009). There-
fore, the efficiency of wtEGFR and 21KR recruitment into coated 
pits was compared by incubating cells with EGF-Rh for a short 
time (1 min) at 37°C. Based on the time course of binding and   
internalization of 
125I-EGF, there is a substantial EGF binding to 
surface receptors at the 1-min time point without significant inter-
nalization. In contrast to experiments at 4°C, the extent of EGF-Rh 
can occur at different 
125I-EGF concentrations. Therefore, inter-
nalization saturation experiments were performed using a range   
of 
125I-EGF concentrations (1–20 ng/ml) to compare the maxi-
mally high internalization rates among all clones. Consistently 
with the results of time course internalization assays using 1 ng/ml   
125I-EGF (Fig. 2 B), progressive decreases in the maximum inter-
nalization rate were observed as the redundant pathways were 
eliminated by mutations (Fig. 2 C). Importantly, the maximum 
internalization rate of the 21KRAP2 mutant was 20–30% to 
that rate of wtEGFR. Altogether, these results suggest that ubiqui-
tination of the kinase domain, C-terminal Lys, and AP-2–binding 
motifs all contribute to EGFR internalization process and likely 
represent the redundant mechanisms of this internalization.
To further test whether AP-2 and Lys residues function re-
dundantly in EGFR internalization, the effect of AP-2 depletion on 
the internalization of wtEGFR, 21KR, and wtAP2 mutant was 
examined using siRNA targeting µ2 subunit of AP-2. AP-2 can re-
cruit cargo to coated pits by means of direct or indirect interaction 
with the cargo (Traub, 2009), and AP-2 also has a general function 
in the formation of coated pits and vesicles (McMahon and Mills, 
2004). Therefore, it is expected that depletion of AP-2 would differ-
entially affect endocytosis of a cargo that binds AP-2 directly (such 
as wtEGFR) and that does not bind AP-2 directly (such as wtAP2 
mutant). Indeed, AP-2 depletion reduced the internalization rate 
of both wtEGFR and wtAP2 (Fig. 3 A). However, the effect of 
µ2 siRNA on wtAP2 receptor internalization was less (50% de-
crease) than on wtEGFR internalization (75% decrease), whereas 
AP-2 was similarly depleted in both cell lines (Fig. 3 B). This result 
is consistent with a model in which AP-2 has a smaller contribu-
tion to internalization of the wtAP2 mutant as compared with 
wtEGFR because the former mutant does not directly bind AP-2. 
Furthermore, AP-2 knockdown decreased the internalization rate   
of the 21KR mutant (Fig. 3 A), which confirmed that AP-2 inter-
actions play an important role in endocytosis of the 21KR mutant.
Internalization-defective EGFR mutants are 
poorly recruited into clathrin-coated pits
To  determine  whether  slow  internalization  of  21KR  and 
21KR∆AP2 mutants was caused by inefficient recruitment 
Figure 3.  siRNA depletion of AP-2 decreases 
internalization of 
125I-EGF to a various degree in 
cells expressing wtEGFR, WTAP2, and 21KR 
receptors.  (A)  Internalization  rate  constants 
(ke) were measured using 1 ng/ml 
125I-EGF in 
wtEGFR, WTAP2, and 21KR-expressing cells 
that were transfected with nontargeting siRNA 
(NT) or siRNA targeting µ2 subunit of AP-2. 
Bars  represent  SEM  from  four  experiments.   
(B) Lysates of cells used in internalization exper-
iments described in A were probed by West-
ern blotting (WB) with Ab32 to -adaptin and 
actin  antibody  (loading  control).  All  images 
are from the same Western blot. The efficiency 
of siRNA depletion (KD%) was calculated as 
a percentage of the intensity of the -adaptin 
signal in depleted cells to that intensity in non-
targeting siRNA–transfected cells (both signals 
were first normalized to the loading control). 
Black lines indicate that intervening lanes have 
been spliced out.875 EGF receptor endocytosis • Goh et al.
We have previously shown that during EGFR endocytosis, Tyr6 
in the 2 subunit of AP-2 (2-adaptin) is phosphorylated by acti-
vated EGFR and that this phosphorylation is strongly dependent 
on the LL
1010/1011 motif of the EGFR (Huang et al., 2003). The 
interaction of the LL
1010/1011 motif with AP-2 is likely of low 
affinity, as it could not be detected by coimmunoprecipitation, 
and the phosphorylation of AP-2 can be considered as an indi-
rect measure of the interaction. Therefore, the ability of EGFR 
mutants to phosphorylate 2-adaptin was tested by immuno-
precipitating AP-2 from EGF-stimulated cells and probing the 
immunoprecipitate with phosphotyrosine antibodies. As shown 
in Fig. 5 A, wtEGFR and 15KR mutant phosphorylated AP-2 
localization in coated pits was two times lower in cells expressing 
21KR mutant than wtEGFR, although EGF-Rh–occupied recep-
tors were mainly clustered. (Fig. 4, B and C). Similar to experi-
ments performed at 4°C, localization of the 21KRAP2 mutant 
in coated pits at 37°C was minimal (3.5%; Fig. 4 C). Collectively, 
these data suggest that the 21KR mutant is impaired in the ability 
to interact with coated pit proteins.
Considering the hypothesis of the redundant role of EGFR 
Lys residues and AP-2–binding motifs, it is unclear why the 
21KR mutant, which contains AP-2–binding motifs, is internal-
ization impaired. One possibility could be that Lys residues and 
their  modifications  regulate  receptor  interactions  with AP-2.   
Figure 4.  Recruitment of EGF-Rh into clathrin- 
coated  pits  is  impaired  in  cells  expressing 
21KR and 21KRAP2 mutants. (A) PAE cells 
expressing  wtEGFR,  WTAP2,  21KR,  and 
21KRAP2  were  transiently  transfected  with 
pcDNA3.1–2-YFP. After 2 d, the cells were 
incubated with 4 ng/ml EGF-Rh for 45 min at 
4°C and fixed. A z stack of optical sections 
was  acquired  through  CY3  (EGF-Rh)  and 
FITC  (2-YFP)  filter  channels  and  deconvo-
luted. 21KRAP2 was mostly localized to the 
ruffles at cell periphery. (B) PAE cells express-
ing wtEGFR and 21KR were transiently trans-
fected with pcDNA3.1–2-YFP. After 2 d, the 
cells were incubated with 4 ng/ml EGF-Rh for   
1 min at 37°C and fixed. A z stack of optical 
sections was acquired through CY3 (EGF-Rh) 
and FITC (2-YFP) filter channels and decon-
voluted. (A and B) Insets show enlarged views 
of boxed areas with CY3 filter channel shifted 
300 nm to the right to better demonstrate 
the  localization  of  EGF-Rh  in  coated  pits.   
Bars, 10 µm. (C) At least 10 images obtained 
for each cell clone as described in A and B 
were  used  to  quantitate  the  percentage  of 
rhodamine fluorescence colocalized with the 
punctate  2-YFP  fluorescence  dots  (coated 
pits). Error bars indicate SEM.JCB • VOLUME 189 • NUMBER 5 • 2010   876
peptide was detected in human head and neck squamous carci-
noma cells expressing high levels of endogenous EGFR, although 
in these cells, the acetylation was EGF dependent (unpublished 
data). Thus, it is possible that acetylation of the distal C-terminal 
Lys regulates EGFR internalization.
Residual internalization of the 21KR∆AP2 
mutant is clathrin and Grb2 dependent
To obtain insights into the mechanisms of the residual internal-
ization of the 21KRAP2 mutant (20–30% wtEGFR), the 
effects of several siRNAs on endocytosis of this mutant were ana-
lyzed. Knockdown of clathrin heavy chain (CHC) substantially 
inhibited internalization of 21KRAP2 (ke = 0.05 min
1; Fig. 7). 
Similarly, siRNA knockdown of the Grb2 adaptor, known to be 
important for ubiquitination and endocytosis of EGFR, strongly 
inhibited 21KRAP2 internalization (Fig. 7) despite a complete 
lack of detectable ubiquitination of this mutant (Fig. S2). siRNAs 
targeting several other proteins specifically implicated in EGFR 
endocytosis or capable of Grb2 binding, such as phospholipase D   
(Lee et al., 2006), CIN85 (Soubeyran et al., 2002), Tom1L1 
(Puertollano, 2005), and intersectin (Martin et al., 2006), did not 
affect internalization of the 21KRAP2 mutant and wtEGFR 
(unpublished data). These data suggest that there is at least an ad-
ditional (fourth) mechanism underlying the CME of EGFR that 
requires Grb2.
Altered dynamics of AKT activation by the 
internalization-defective 21KRAP2 mutant
Although 21KRAP2 mutant could still be internalized at a slow 
rate, the internalization rate of this mutant approximates the rate 
of constitutive endocytosis. Therefore, it is expected that EGF 
would  not  cause  significant  accumulation  of  the  21KRAP2 
mutant in endosomes. Analysis of the localization of this mutant 
stimulated with EGF-Rh at 37°C demonstrated that the appearance 
of the mutant receptor in endosomes containing EEA.1 (early 
endosomal antigen 1) was dramatically delayed as compared with 
cells expressing wtEGFR (Fig. 8 A). 21KRAP2 did not signifi-
cantly colocalize with EEA.1 for up to 1 h after EGF stimula-
tion. This result confirmed that in cells expressing 21KRAP2 
receptor, most of the EGF-activated receptors remained at the 
cell surface, whereas in cells expressing wtEGFR, there was a 
large pool of EGF-occupied receptors in endosomes. Because 
nonubiquitinated EGFR mutants are not efficiently sorted to late 
to a similar extent, which indicates a similar extent of receptor   
interaction  with AP-2.  wtAP2  did  not  phosphorylate  2   
despite normal recruitment to coated pits and endocytosis, support-
ing the hypothesis that this mutant utilizes AP-2–independent 
mechanisms of internalization (Fig. 5, A and B). Interestingly, 
2-adaptin was only negligibly phosphorylated by the 21KR 
mutant (Fig. 5 A), which suggests that this mutant very weakly 
and/or only transiently interacts with AP-2. The weak 2 
phosphorylation by the 21KR mutant was not caused by the 
direct effect of C-terminal Lys mutations because the 6KR-C   
mutant  displayed  normal  capacity  to  phosphorylate AP-2 
(Fig. 5 B). In summary, the decreased recruitment into coated 
pits at 37°C and slow internalization of the 21KR mutant cor-
related with its inability to phosphorylate 2-adaptin. These 
data support the hypothesis that EGFR Lys and possibly post-
translational modifications of these residues regulate the inter-
action of the receptor with AP-2.
Three distal Lys in the C terminus  
are critical for EGFR internalization  
and are acetylated
To further elucidate the mechanism by which C-terminal Lys reg-
ulate EGFR internalization, we tested which of these six Lys are 
responsible for the slow internalization of the 21KR mutant. Sys-
tematic arginine to Lys add-back mutations in the C-terminal tail 
of 21KR were made, and several monoclonal lines in PAE cells 
were generated (Fig. 6 A). Restoration of three kinase-proximal   
Lys (1037, 1075, and 1136) did not significantly rescue the inter-
nalization rate, whereas add back of three distal Lys (1155, 1158, 
and 1164) rescued EGFR internalization to the level of internal-
ization observed for wtEGFR and 6KR-C mutant (Fig. 6 B). These 
data suggest that Lys1155, Lys1158, and Lys1164 are involved 
in the regulation of EGFR internalization. Individual and double 
mutations of these Lys did not significantly affect internalization 
of the 15KR mutant, indicating that the role of these three Lys is 
redundant (Fig. 6 B).
MS analysis of wtEGFR-expressing PAE and other types 
of cells untreated or treated with EGF did not reveal ubiquitin 
conjugation of C-terminal Lys. Surprisingly, a peptide encom-
passing Lys1155, Lys1158, and Lys1164, in which all three Lys 
residues were acetylated, was identified several times (Fig. 6 C). 
Acetylation of these Lys was observed in wtEGFR/PAE cells in-
dependently of EGF treatment (Fig. 6 D). An identical acetylated 
Figure 5.  EGF-induced tyrosine phosphoryla-
tion of 2-adaptin is impaired in cells express-
ing 21KR and various AP-2–binding motif EGFR 
mutants.  PAE  cells  expressing  wtEGFR  and 
various mutants were untreated or treated with 
100 ng/ml EGF for 5 min, lysed, and AP-2 was 
immunoprecipitated  (IP)  with  AP.6  antibody. 
Immunoprecipitates  were  blotted  with  phos-
photyrosine antibody (pY20) and antibody to 
-adaptin  (AC.1).  Overexposed  blot  demon-
strates the presence of the weak pY20 signal in 
AP-2 immunoprecipitates from 21KR-expressing 
cells. Aliquots of lysates (bottom) were blotted 
with antibodies to phospho-Tyr1068 of EGFR 
and total EGFR (1005). Two representative ex-
periments (A and B) are shown.877 EGF receptor endocytosis • Goh et al.
capable of activating upstream components of the AKT signal-
ing  cascade.  However,  although AKT  phosphorylation  was 
sustained  in  wtEGFR-expressing  PAE  cells,  the  amount  of 
phosphorylated AKT rapidly decreased to 50% by the 15-min 
time point in cells expressing the 21KRAP2 mutant (Fig. 8, 
B and C). These data suggest that internalization is necessary 
for normal kinetics of AKT activation by EGFR. In contrast, 
phosphorylation  of  MAPK/extracellular  stimulus–regulated 
kinase 1/2 (ERK1/2) in cells expressing 21KRAP2 mutant 
was relatively long lasting when compared with wtEGFR-
expressing cells (Fig. 8, B and C), suggesting that EGFR 
endocytosis  primarily  down-regulates  ERK1/2  signaling.   
endosomes and remain in early/recycling endosomes (Huang   
et al., 2006), enhanced recycling of the 21KRAP2 mutant may 
amplify the effect of its slow internalization, thus resulting in its 
predominant cell surface localization.
To assess whether activation of the internalization-defective 
21KRAP2 mutant results in altered signaling outcome, cells 
expressing wtEGFR or 21KRAP2 mutant were incubated 
with 5 ng/ml EGF at 37°C. Western blot analysis of phospho-
EGFR revealed prolonged phosphorylation of the 21KRAP2 
mutant as compared with wtEGFR (Fig. 8 B). Both wtEGFR 
and the 21KRAP2 mutant initially activated protein kinase B/ 
AKT to the same extent, suggesting that the mutant receptor is   
Figure 6.  Three distal Lys in the C terminus 
of  EGFR  (K1155,  K1158,  and  K1164)  are 
important  for  internalization  and  are  acety-
lated. (A) Schematic representation of 21KR 
+  R1037/1075/1136K,  21KR  +  R1155/
1158/1164K, 15KR + K1164R, and 15KR + 
K1155/1158R EGFR mutants. (B) Internaliza-
tion rates of 1 ng/ml 
125I-EGF are compared in 
cells expressing wtEGFR, 6KR-C, and mutants 
depicted in A. Error bars indicate mean values 
of ke (SEM) obtained in two individual single-
cell clones for each mutant. (C) MS analysis 
of wtEGFR immunoprecipitates from PAE cells 
treated and untreated with EGF. Representa-
tive MS/MS spectrum of EGFR with acetylation 
(Ac) at Lys 1155, 1158, and 1164 and the 
sequence of the peptide. The precursor pep-
tide  ion  (m/z  837.4064)  was  isolated  and 
fragmented in a mass spectrometer. Fragment 
ions included both the N and C termini (b and 
y ions, respectively) in which the detected ions 
are underlined. (D) The ion charge state, mass 
deviation, Sequest score (XCorr), and experi-
mental condition are shown for the peptides 
containing  Lys1155,  1158,  and  1164  that 
were identified. In addition, a tryptic peptide 
containing unmodified Lys1155 was identified 
multiple times (not depicted).JCB • VOLUME 189 • NUMBER 5 • 2010   878
maintained normal tyrosine phosphorylation and was capable of 
phosphorylating exogenous substrates (Figs. S2 and S3).
The precise role of the three distal C-terminal Lys, which 
appear to be mainly responsible for the observed slow internal-
ization of 21KR receptor, is unknown. The simplest explanation 
is that these Lys are ubiquitinated in the absence of major conju-
gation sites in the kinase domain; however, such ubiquitination 
is neither detected by MS nor by Western blotting. MS analy-
sis instead revealed a novel posttranslational modification of 
EGFR by acetylation (Fig. 6 C). Strikingly, Lys1155, Lys1158, 
and Lys1164 that are important for EGFR internalization (Fig. 6)   
were the only acetylated Lys in the EGFR that were identified 
in our analysis. It is common that acetylation occurs at clusters 
of Lys residues that form positive patches, as it occurs in the 
distal C terminus of EGFR. Lys acetylation has been shown to 
regulate protein function in coordination with phosphorylation 
and ubiquitination (Yang and Seto, 2008). Thus, Lys acetylation 
may have either a direct, positive effect, or an opposite, inhibi-
tory function on EGFR endocytosis, for instance, by competing 
with  ubiquitination  of  these  Lys.  Unfortunately,  all  available 
acetyltransferase inhibitors were highly toxic to PAE cells un-
der various experimental conditions, precluding the analysis of 
the effects these inhibitors on the endocytosis of EGFR mutants 
(unpublished data). Finally, it is also possible that C-terminal Lys 
are a part of an internalization motif. For instance, the QQDFF 
sequence was shown to be capable of mediating CME (Chang   
et al., 1993). Such a sequence (residues 1149–1153) is present in 
the proximity to the three distal Lys of EGFR and can potentially 
regulate endocytosis in conjunction with these Lys.
The role of yet another internalization mechanism that in-
volves EGFR binding to AP-2 was revealed when AP-2–binding   
motifs  of  EGFR  (Y
974RAL  and  LL
1010/1011)  were  mutated  in 
combination with the mutation of Lys in the kinase domain and 
C terminus. Although the YRAL motif is critical for the receptor   
Altogether,  these  data  imply  that  EGFR  endocytosis  can 
have both positive and negative effects on its downstream 
signaling molecules.
Discussion
Since the first comprehensive analysis of EGF endocytosis   
(Carpenter and Cohen, 1976) and cloning of EGFR (Downward 
et al., 1984), >1,000 publications have addressed the mechanisms 
of EGFR endocytosis and the role of endocytosis in EGFR signal-
ing. This study provides an explanation as to why previous stud-
ies produced many nonreconcilable models of these processes by 
demonstrating the extreme complexity of the clathrin-dependent 
internalization of EGFR, which appears to be mediated by several 
redundant and interdependent mechanisms. A hypothetic model 
of the EGFR CME is described in Fig. 9.
Ubiquitination of Lys within the kinase domain is one of 
the mechanisms that can promote EGFR internalization. Inhibi-
tion of ubiquitination by mutating ubiquitin conjugation sites or   
Cbl-binding site (Tyr1045) in the EGFR did not affect internaliza-
tion, thus indicating that ubiquitination is not essential for recep-
tor internalization (Waterman et al., 2002; Huang et al., 2007). 
Similarly, normal endocytosis of the ubiquitination-deficient mu-
tant of the fibroblast growth factor receptor, another receptor ty-
rosine kinase, has also been demonstrated previously (Haugsten 
et al., 2008). However, add back of two major ubiquitin conju-
gation sites restored the internalization of the ubiquitination and 
kinase activity–deficient EGFR mutant, providing the first indi-
cation that ubiquitination of the EGFR kinase domain is capable 
of promoting receptor internalization under specific conditions 
(Huang et al., 2007). In this study, the involvement of ubiquitina-
tion of the kinase domain was revealed when Lys in the kinase 
domains and C terminus were simultaneously mutated (Figs. 1 
and 2). In this case, the internalization-defective EGFR mutant 
Figure  7.  siRNA  depletion  of  Grb2  and 
CHC  decreases  internalization  of 
125I-EGF 
in cells expressing wtEGFR and 21KRAP2 
mutant.  (A)  Internalization  rate  constants 
(ke) were measured using 1 ng/ml 
125I-EGF 
in wtEGFR and 21KRAP2-expressing cells 
that  were  transfected  with  nontargeting 
siRNA  (NT)  or  siRNA  targeting  Grb2  or 
CHC.  Error  bars  indicate  SEM  from  three 
experiments.  (B)  Lysates  of  cells  used  in 
internalization  experiments  described  in  A   
were probed by Western blotting with anti-
bodies  to  CHC,  Grb2,  and  actin  (load-
ing control). All images are from the same 
Western blot (WB). Black lines indicate that   
intervening lanes have been spliced out.879 EGF receptor endocytosis • Goh et al.
interaction with the LL motif. Poor phosphorylation of 2-adaptin 
by the 21KR mutant (Fig. 5) can be the consequence of weak bind-
ing of this mutant to AP-2 and, therefore, short residence time   
in coated pits or vice versa, which is a basis for the insufficient   
LL–AP-2 interaction and coated pit recruitment of the mutant re-
ceptor. It is possible that ubiquitination of Lys in the kinase domain 
and/or posttranslational modifications of C-terminal Lys may cause 
conformation changes in the EGFR molecule, leading to better ex-
posure of AP-2–binding motifs, as was suggested for the interferon 
receptor (Kumar et al., 2007). Furthermore, our model also implies 
that coated pit accumulation of receptors lacking AP-2 binding, 
such as the wtAP2 mutant, can be achieved by alternative, e.g., 
ubiquitin-based, mechanisms.
Finally, the residual internalization of the 21KRAP2 
mutant is controlled by yet another mechanism. siRNA analy-
sis demonstrated that internalization of 21KRAP2 is par-
tially clathrin dependent and also requires Grb2. It should be 
emphasized that Grb2 plays a role in all ubiquitin-dependent 
mechanisms of EGFR endocytosis by delivering Cbl to EGFR 
interaction with AP-2 in cell lysates and in vitro, it is unlikely 
that this motif is involved in such interaction in the intact cell. 
A recent study suggested that the YRAL sequence is part of an 
-helix and is not present in an extended conformation neces-
sary for binding to the µ2 subunit of AP-2 (Jura et al., 2009). 
In fact, denaturing conditions and ionic detergents resulted in 
an increased interaction of the EGFR YRAL motif with AP-2 
(Nesterov et al., 1995; Sorkin et al., 1996).
Furthermore, when YRAL motif was mutated, coimmuno-
precipitation of AP-2 with EGFR was not observed (Sorkin et al., 
1996). This suggests that the interaction between the LL motif of 
EGFR and AP-2 is very weak and transient. In fact, the LL motif 
in EGFR lacks a negatively charged residue in the 4 position, 
which is frequently present in the LL-based motifs of other pro-
teins. However, recent structure of AP-2 complexed with the LL 
peptide suggested that such negative charge is not an absolute re-
quirement (Kelly et al., 2008). Importantly, this study also pre-
dicted that phosphorylation of Tyr6 in 2-adaptin would shift the 
AP-2 complex to an active, open conformation capable of efficient 
Figure 8.  Poor accumulation of 21KRAP2 mutant in endosomes and altered kinetics of ERK1/2 and AKT activation by EGF in cells expressing the internal-
ization-defective mutant. (A) PAE cells expressing wtEGFR and 21KRAP2 were incubated with 5 ng/ml EGF-Rh for 15 min or 1 h. After fixation, the cells 
were permeabilized and stained with antibody to EEA.1. A z stack of optical sections was acquired through CY3 (EGF-Rh) and FITC (EEA.1) filter channels 
and deconvoluted. Insets show enlarged views of the boxed areas, showing localization of wtEGFR in EEA.1-containing early endosomes. 21KRAP2 
mutant was accumulated in the membrane ruffles (arrows). Bars, 10 µm. (B) Serum-starved cells were treated with 5 ng/ml EGF for 0–120 min at 37°C 
and lysed. The lysates were probed for active EGFR (pY1045 and pY1086), total EGFR (1005), phosphorylated AKT (p-AKT), total AKT, phosphorylated 
ERK1/2 (p-ERK1/2), and total ERK1/2. The experiment is representative of three independent experiments. Gray line indicates that intervening lanes have 
been spliced out. (C) Quantification of experiments presented in B. Bars represent SEM of the amounts of activated EGFR, AKT, and ERK1/2 normalized to 
total amounts of EGFR, AKT, and ERK1/2, respectively, and plotted against time. The data are averaged from three experiments. WB, Western blot.JCB • VOLUME 189 • NUMBER 5 • 2010   880
internalization. It is possible that the relative contribution of 
one of the internalization mechanisms may vary in different 
cell types and depend on experimental conditions. Importantly, 
the existence of multiple internalization mechanisms does not 
necessarily imply that all mechanisms are simultaneously used.   
Instead, one mechanism may be predominantly used under physi-
ological conditions, whereas other mechanisms are used only   
when the main mechanism is inhibited experimentally or under   
pathological conditions. It is interesting that two rate-limiting   
steps of EGFR down-regulation exhibit drastically different 
robustness (Fig. 9). Unlike the internalization step, the endo-
somal sorting to the degradation pathway is highly dependent 
on EGFR ubiquitination and, therefore, mainly controlled by 
a single, ubiquitin-based mechanism (Levkowitz et al., 1999; 
Huang et al., 2006).
The first internalization-defective EGFR mutant with 
normal  tyrosine  phosphorylation  generated  in  this  study 
(21KRAP2) is a novel and specific tool to investigate the 
role of EGFR endocytosis in signaling. As was observed with 
the EGFR mutants defective in lysosomal targeting (Levkowitz   
et al., 1999; Huang et al., 2006), degradation of activated 
21KRAP2  was  substantially  delayed  as  compared  with 
wtEGFR (Fig. 8). However, in contrast to degradation-defective   
mutants, 21KRAP2 mutant did not fully maintain AKT ac-
tivity, suggesting that continuous activity of AKT requires 
EGFR internalization (Fig. 8). This finding contradicts the 
general assumption in the literature that the AKT activation 
pathway is mostly initiated at the plasma membrane, where 
phosphatidylinositol-(3,4,5)-phosphate is generated, whereas 
the EGFR-ERK1/2 signaling can also be triggered from en-
dosomes (Haugh and Meyer, 2002; Sadowski et al., 2009; for 
reviews see Wiley, 2003; Fehrenbacher et al., 2009; Sorkin 
and von Zastrow, 2009). It is possible that endosomal EGFR 
is required for activation of a pool of AKT associated with 
Appl1/2 (adaptor protein, phosphotyrosine interaction, PH 
domain, and Leu zipper containing–1), an endosomal pro-
tein that recruits AKT and facilitates phosphorylation of its 
downstream substrate, glycogen synthase kinase-3 in Rab5- 
containing endosomes (Schenck et al., 2008). Recently, an-
other endosomal adaptor protein, WDFY2, was found to be 
necessary for maintaining insulin-stimulated AKT2 phosphory-
lation (Walz et al., 2010). Finally, another possible explanation 
is that accumulation of internalization-defective EGFR at the 
cell surface triggers a negative feedback loop by up-regulating   
an AKT phosphatase, which results in down-regulation of 
active AKT.
The role of endocytosis in ERK1/2 activation by EGF has 
been previously demonstrated using general inhibitors of CME 
(Vieira et al., 1996), although other studies using the same in-
hibitors produced conflicting results with regard to the role 
of endocytosis in ERK activity (for reviews see Wiley, 2003; 
Fehrenbacher et al., 2009; Sorkin and von Zastrow, 2009).   
In our experiments, ERK1/2 activation was not inhibited and even 
slightly prolonged in cells expressing the 21KRAP2 receptor 
(Fig. 8). Thus, endocytosis of activated EGFR may primarily 
serve to down-regulate rather than enhance EGFR-ERK1/2 sig-
naling. In summary, our experiments have taken the experimental 
(for review see Sorkin and Goh, 2009). In the case of the 
21KRAP2 receptor, it is likely that Grb2 links the recep-
tor to coated pits through ubiquitin-independent mechanisms 
and unknown adaptors. In addition to its role in CME, Grb2 
has been shown to be important for clathrin-independent en-
docytosis of EGFR (Yamazaki et al., 2002). Therefore, Grb2 
knockdown has the major inhibitory effect on the total uptake 
of EGF by wtEGFR and 21KRAP2 mutant (Fig. 7). Lastly, 
early  studies  in  mouse  fibroblasts  demonstrated  that  EGFR 
mutants with deletions of the C terminus at the position 1022 
(eliminating  Grb2-  and  Cbl-binding  sites)  were  rapidly  in-
ternalized in a kinase-dependent manner (Chen et al., 1989), 
although the same mutants were internalized very slowly in 
PAE cells (Jiang et al., 2003). These data suggest that in some 
cells, there might be yet another mechanism of EGFR internal-
ization that requires kinase activity but does not require Grb2 
binding, receptor ubiquitination, and a large portion of the   
C terminus. Finally, another level of complexity is added by the 
recent report of the clathrin-mediated but kinase-independent 
internalization of EGFR (Frosi et al., 2010). In this case, inter-
nalization is mediated by the protein called receptor-associated 
signal transducer (RALT or MIG6) that is capable of binding to 
the dimerized EGFR, inhibiting its kinase activity and linking 
the receptor to coated pits through the interaction with AP-2 
and intersectins.
In summary, our experiments reveal several redundant 
and, in some cases, interdependent mechanisms of EGFR inter-
nalization involving AP-2, Grb2, ubiquitination, and possibly 
Lys acetylation. The sheer complexity of EGFR internalization 
may help to explain discrepancies in the literature regarding 
the role of AP-2 and ubiquitin adaptors like epsin in EGFR   
Figure 9.  Working model of EGFR internalization and lysosomal targeting. 
Grb2/Cbl-dependent ubiquitination of the kinase domain (mechanism #1)   
and C-terminal Lys (mechanism #2) functionally interact with AP-2 bind-
ing of the receptor (mechanism #3) in contributing to 70–80% of EGFR 
internalization. The CME (mechanism #4) involves other unknown Grb2- 
related mechanisms. Clathrin-independent mechanisms of EGFR internal-
ization constitute 5–15% of the overall uptake of EGF–EGFR complexes 
into the cell. These mechanisms may involve Grb2, actin-dependent mem-
brane ruffling, and cholesterol-rich membrane microdomains (rafts).881 EGF receptor endocytosis • Goh et al.
(Sigma-Aldrich) for 1 h at 4°C. The precipitates were washed twice with 
TGH lysis buffer supplemented with 100 mM NaCl and once without NaCl. 
Samples were resuspended in sample buffer and heat denaturated.
For immunoprecipitation of AP-2, c-Cbl, or Shc, PAE cells expressing 
wt and mutant EGFR were stimulated with 100 ng/ml (for AP-2) or 20 ng/ml 
(for c-Cbl and Shc) EGF for 5 min at 37°C, and the cells were lysed as de-
scribed previously (Huang et al., 2004). AP-2, c-Cbl, or Shc was immuno-
precipitated using AP6, c-Cbl (C-15), or Shc antibodies (BD), respectively, 
for 3 h at 4°C followed by protein A–Sepharose beads (Sigma-Aldrich) or 
protein G–Sepharose beads (Invitrogen) for 1 h at 4°C. The samples were 
washed and heat denatured as described in the previous paragraph.   
To examine EGFR signaling, the cells grown in 35-mm dishes were serum 
starved overnight, stimulated with 5 ng/ml EGF, and lysed in TGH lysis 
buffer without NaCl.
The  immunoprecipitates  and  cell  lysates  were  resolved  on  7.5% 
SDS-PAGE. Proteins were transferred to the nitrocellulose membrane and 
probed by Western blotting with various antibodies followed by species-
specific  secondary  antibodies  conjugated  with  horseradish  peroxidase 
(The Jackson Laboratory). Detection of signal was performed with an en-
hanced chemiluminescence kit (Thermo Fisher Scientific). To determine the 
linear range of chemiluminescence signal, several x-ray films (Thermo Fisher 
Scientific) were analyzed, and the densitometric quantifications were per-
formed using ImageJ software (National Institutes of Health).
MS
PAE cells stably expressing wtEGFR were grown in 150-mm dishes. Cells 
were untreated or treated with 2 or 20 ng/ml EGF for 5 min at 37°C, 
washed with CMF-PBS, and lysed in TGH containing 1% sodium deoxy-
cholate. Lysate was cleared by centrifugation at 14,000 g for 10 min. 
EGFR was immunoprecipitated with monoclonal antibody 528 (ATCC). 
The precipitates were washed three times with TGH containing, sequen-
tially,  500  mM,  100  mM,  and  no  NaCl,  and  resolved  by  SDS-PAGE 
(Huang et al., 2006). Acetylation sites on hEGFR were identified by liquid 
chromatography MS/MS techniques described previously (Haas et al., 
2006). In brief, hEGFR was digested in gel with trypsin. The peptides were 
separated by nanoscale reversed chromatography coupled to a mass spec-
trometer (LTQ-Orbitrap; Thermo Fisher Scientific). MS/MS data were col-
lected on a data-dependent method described previously (Haas et al., 
2006). Mass increment of 42.0106 (acetylation) was allowed on Lys resi-
dues for MS/MS spectra matched to hEGFR using Sequest algorithm (Eng 
et al., 1994).
Internalization of 
125I-EGF
Mouse receptor-grade EGF (Collaborative Research, Inc.) was iodinated 
as previously described (Nesterov et al., 1999). In most experiments, the 
time  course  of 
125I-EGF  internalization  was  obtained  using  1  ng/ml   
125I-EGF, and the specific rate constant for internalization ke was calculated 
as the linear regression coefficient of the dependence of the ratio of inter-
nalized/surface 
125I-EGF versus time as previously described (Nesterov et al., 
1999). This low concentration of 
125I-EGF was used to avoid saturation of 
the clathrin-mediated internalization pathway. In internalization saturation 
experiments, the ke values were determined for the range of 
125I-EGF con-
centrations (1–20 ng/ml) and plotted against the amount of surface   
125I-EGF–occupied receptors per cell. The latter value was determined at a 
5-min time point of the 
125I-EGF internalization assay as described previ-
ously (Huang et al., 2006).
Fluorescent microscopy
To visualize clathrin-coated pits, 2-YFP was transiently expressed in PAE 
cells stably expressing wt or EGFR mutants in six-well plates. 24–36 h after 
transfection, the cells were replated onto 25-mm glass coverslips. The cells 
were incubated with 4 ng/ml EGF-Rh (Invitrogen) for 45 min at 4°C or for 
1 min at 37°C. The cells were washed with ice-cold CMF-PBS and fixed 
with  freshly  prepared  4%  paraformaldehyde  (Electron  Microscopy  Sci-
ences) for 30 min at 4°C. The coverslips were mounted on glass slides   
using Mowiol (Invitrogen). Detection of YFP and rhodamine fluorescence 
was performed as previously described (Sorkina et al., 2002; Jiang et al., 
2003). A z stack of 30 images for at least 10 cells per each condition was 
acquired using an imaging workstation (Marianas; Intelligent Imaging Inno-
vations, Inc.) based on an inverted microscope (300M; Carl Zeiss, Inc.) with 
a 63× 1.2 NA oil objective and a charge-coupled device camera (CoolSnap 
HQ2; Photometrics) controlled by Slidebook software (version 4.2; Intelli-
gent Imaging Innovations, Inc.). Images were acquired in 2 × 2 binning 
mode. The three-dimensional images were deconvoluted using a constrained 
iterative algorithm (Slidebook). The percentage of total cell-associated 
approaches  to  specifically  inhibit  EGFR  endocytosis  and  to 
generate valuable tools for comprehensive analysis of the role 
of EGFR endocytosis in signaling.
Materials and methods
Antibodies
Mouse monoclonal antibody to ubiquitin (P4D1), rabbit polyclonal anti-
bodies to Grb2, Cbl (C-15), Shc (H-108), and EGFR (1005) were purchased 
from Santa Cruz Biotechnology, Inc. The monoclonal antibodies to EGFR 
(Ab528), -subunit of AP-2 (AP.6), and CHC (TD.1) were obtained from 
American Type Culture Collection (ATCC). Monoclonal antibodies specific 
to phosphotyrosine (pY20), c-Cbl, Shc, and EEA.1 were obtained from BD. 
Monoclonal antibodies to phospho-EGFR (pY1068), phospho-AKT (Ser473), 
phospho-ERK1/2 (Thr202/Tyr204), and polyclonal antibodies to phospho-
EGFR (pY1045), total AKT, and total ERK1/2 were obtained from Cell Sig-
naling Technology. Rabbit polyclonal antibody to phospho-EGFR (pY1086) 
and monoclonal antibody to -adaptin (AC.1) were obtained from Thermo 
Fisher Scientific. Polyclonal antibody to actin was obtained from Sigma-
Aldrich. Rabbit polyclonal antibody specific to -adaptins (Ab32) was de-
scribed previously (Sorkin et al., 1995).
Plasmid constructs and point mutations
To generate EGFR mutant 21KR, six Lys residues in the C-terminal tail of 15KR 
(Huang et al., 2007) were mutated to arginines. To generate EGFR mutants 
15KRAP2 and 21KRAP2, Tyr
974, Leu
1010, and Leu
1011 were mutated to ala-
nine on the template of 15KR and 21KR, respectively. All mutations were per-
formed using multisite-directed mutagenesis kits according to the manufacturer’s 
protocols (QuickChange; Agilent Technologies). All point mutations were veri-
fied by automated dideoxynucleotide sequencing (Sequencing Core Facility, 
University of Colorado Denver, Aurora, CO). 2-YFP construct was made in 
pcDNA3.1 as previously described (Huang et al., 2003).
Cell culture and DNA transfection
PAE cells were grown in F12 medium containing 10% FBS. Transfections of 
DNA constructs were performed using Effectene (QIAGEN) according to 
the manufacturer’s protocols. PAE cells stably expressing various EGFR   
mutants were selected with 400 ng/ml geneticin (G418), and single-cell 
clones were established. Stable clones were maintained in the presence of 
400 ng/ml G418. HEK293 cells were grown in DME containing 10% 
FBS. Transient transfection was performed using Effectene. Human head 
and neck squamous cell carcinoma SCC2 and intestinal adenocarcinoma 
HuTu 80 were grown in DME containing 5% FBS.
siRNA transfections
Synthetic siRNAs for CHC (duplex 2; Huang et al., 2004), Grb2 (duplex 3; 
Jiang et al., 2003), AP-2 µ2 subunit (Motley et al., 2003), ON-TARGET 
Cbl-interacting protein 85 (CIN 85; SMARTpool), siGENOME intersectin 1 
(SMARTpool), phospholipase D1 (5-GGUGGGACGACAAUGAGCA-3), 
siGENOME TOM1L1 (SMARTpool), and siGENOME nontargeting siRNA 
#3 were purchased from Thermo Fisher Scientific. Duplexes were resus-
pended in 1× siRNA universal buffer (Thermo Fisher Scientific) to 20 µM. 
PAE cell lines expressing various EGFR mutants were grown in six-well 
plates to 50% confluence. Cells were transfected with siRNA duplexes,   
either singly or in combination, to the final concentration of 120 nM in   
5 µl DharmaFECT1 reagent (Thermo Fisher Scientific). After 36 h, a second 
transfection was performed, and the cells were replated into 12-well plates 
on the next day for internalization experiments. To access the efficiency of 
knockdown, total cell lysates were resolved on 7.5% or 10% SDS-PAGE 
depending on the protein of interest and probed by Western blotting.
Immunoprecipitation and Western blotting
To examine the extent of ubiquitination and tyrosine phosphorylation, PAE 
cells stably expressing wtEGFR or EGFR mutants were grown in 60-mm 
dishes for 2 d and stimulated with 20 ng/ml EGF in binding medium (0.1% 
bovine serum albumin in F12) for 5 min at 37°C. The cells were washed 
twice with Ca
2+Mg
2+-free (CMF) PBS and solubilized by scraping with a 
cell lifter in TGH lysis buffer (50 mM Hepes, pH 7.3, 10% glycerol, 1% 
Triton X-100, 50 mM NaCl, 1 mM dithiothreitol, 1 mM EGTA, 5 mM EDTA, 
10 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml   
leupeptin, 10 µg/ml aprotinin, 10 mM N-ethylmaleimide, and 1 mM so-
dium orthovanadate; Huang et al., 2004). The lysates were centrifuged for 
10 min at 14,000 g. EGFR was immunoprecipitated with monoclonal anti-
body 528 (ATCC) for 3 h at 4°C followed by protein A–Sepharose beads JCB • VOLUME 189 • NUMBER 5 • 2010   882
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